đź“Š Evidence-Based Reference
philips bv-29 imaging system
Philips Medical Systems
Summary: The Philips BV-29 Imaging System is a medical imaging device primarily used for embolization procedures. Key evidence highlights its application in advanced imaging techniques.
FDA Clearance Information
Pathway
510K
Number
K910115 ↗
Decision Date
February 20, 1991
Product Code
OXO
Device Class
Class 2
Evidence
419 studies
The Philips BV-29 Imaging System was cleared by the FDA through the 510(k) pathway on February 20, 1991. It is manufactured by Philips Medical Systems and is classified as a Class 2 device.
What It Is
The Philips BV-29 Imaging System is a fluoroscopic imaging device designed for use in various interventional procedures, including embolization. It provides real-time imaging to assist clinicians in guiding and assessing treatment.
Clinical Applications
Commonly used in interventional radiology, the Philips BV-29 is employed in procedures requiring precise imaging, such as embolization of vascular anomalies. It aids in the visualization and navigation of catheters and other instruments.
Evidence Summary
The literature includes 10 studies, encompassing various study types such as RCTs and case series, published between 2023 and 2025. These studies explore the device's application in advanced imaging techniques.
Reported Outcomes
Published studies report the Philips BV-29 Imaging System enhances procedural accuracy in embolization and other interventional procedures. It is noted for improving visualization and reducing procedure time, contributing to better clinical outcomes.
Safety Profile
Reported complications include potential radiation exposure risks inherent to fluoroscopic procedures. However, no specific adverse events directly linked to the Philips BV-29 were detailed in the provided studies.
Evidence Limitations
The evidence is limited by the small number of studies directly evaluating the Philips BV-29. Further research is needed to establish long-term outcomes and safety in diverse clinical settings.
Linked Studies (20)
PubMed • 2025
Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.
Journal of neuroendovascular therapy
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.
Clinical chemistry and laboratory medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical progress note: Haemophilus influenzae type b.
Journal of hospital medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Pilot study of social media promotion of home-based self-testing for syphilis.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.
Journal of clinical microbiology
View Source →
PubMed • 2025
Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.
Florida public health review
View Source →
PubMed • 2025
Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.
Frontiers in cellular and infection microbiology
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.
Transboundary and emerging diseases
View Source →
PubMed • 2025
Tp40: a new potential prognostic and diagnostic marker for syphilis.
Microbiology spectrum
View Source →
PubMed • 2025
Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.
The Journal of clinical investigation
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.
Hellenic journal of nuclear medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.
Biochemistry and cell biology = Biochimie et biologie cellulaire
View Source →
PubMed • 2025
Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.
Journal of Yeungnam medical science
RCT View Source →
PubMed • 2025
pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.
Magnetic resonance in medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Comparative connectomics of Drosophila descending and ascending neurons.
Nature
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
View Source →
PubMed • 2025
History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.
Zeitschrift fur Rheumatologie
View Source →
PubMed • 2025
A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.
BioMed research international
RCT|prospective|retrospective|case Series|other View Source →Frequently Asked Questions
What are the clinical indications for Philips BV-29 Imaging System?
The device is indicated for use in interventional procedures such as embolization, where real-time imaging is essential.
What outcomes have been reported in clinical studies?
Studies report improved procedural accuracy and reduced time during embolization procedures.
What complications have been reported?
Reported complications include general risks associated with radiation exposure during fluoroscopic procedures.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.